US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Latest News about Todos Medical

Recent news which mentions Todos Medical

Meet The Company Developing Advanved Blood Tests To Detect Cancer And Other Diseases
Tickers TOMDF
Tags TOMDF Interview Todos Medical
From Benzinga
Todos Medical Receives New FDA Certificate of Free Sale for Tollovid® Max Strength including 5 Day Dosing, 30 Day Dosing And 3CL Protease (3CLpro, Mpro, Nsp5) Inhibitor Claim
Tickers TOMDF
Tags Partner Content Benzinga General
From Benzinga
Todos Medical Initiates IRB-Waived Tollovid® Market Research Study And Announces 50% Price Reduction Until May 30th, 2022
Tickers TOMDF
Tags Benzinga Partner Content General
From Benzinga
Todos Medical To Present At The Emerging Growth Conference
Tickers TOMDF
Tags Biotech Penny Stocks Market News
From Benzinga
Todos Medical Appoints Philippe Goix As Chief Commercial Officer For Provista Diagnostics
Tickers TOMDF
Tags TOMDF Todos Medical Press Releases
From Benzinga
Todos Medical Reports 2nd Long COVID Case Study And Launches Website For Physicians And Pediatricians To Indicate Interest In Participating In Tollovid® Long COVID Clinical Study
Tickers TOMDF
Tags Partner Content Benzinga General
From Benzinga
Todos Medical Targets Athlete Support with Informed Sport Certification for Tollovid® by LGC Group
Tickers TOMDF
Tags Biotech Penny Stocks Market News
From Benzinga
New Study Reportedly Calls Into Question Merck's Ivermectin COVID Off Label Use And May Bolster 3CL Protease Inhibitors Such As Tollovid
Tickers MRK PFE TOMDF
Tags Todos Medical Market News Biotech
From Benzinga
Todos Medical Applauds White House Initiative on Long COVID and Announces New Tollovid® US FDA Certificate Of Free Sale With Daily And Acute Dosing On The Label
Tickers TOMDF
Tags General Partner Content Benzinga
From Benzinga
Todos Medical Announces Positive 3CL Protease Inhibition In Vitro Data Against BA.1 and BA.2 Omicron SARS-CoV-2 Variants
Tickers TOMDF
Tags Benzinga Partner Content General
From Benzinga
UPDATE: Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
Tickers TOMDF
Tags Press Releases Todos Medical Market News
From Benzinga
Todos Medical Reports Fourth-Quarter And Full-Year 2021 Financial Results And Corporate Updates
Tickers TOMDF
Tags TOMDF Penny Stocks Biotech
From Benzinga
Todos Medical Reports Case Study Of Patient With Long COVID
Tickers TOMDF
Tags Benzinga Partner Content General
From Benzinga
Billy Blanks® Endorses Todos Medical's Line Of Tollovid® Products
Tickers TOMDF
Tags TOMDF Press Releases Todos Medical
From Benzinga
Todos Medical To Present At The Proactive One2One Virtual Forum
Tickers TOMDF
Tags TOMDF Press Releases Todos Medical
From Benzinga
Todos Medical Acquires Lucrative NLC Assets For Pennies On The Dollar
Tickers GILD MRK PFE TOM
Tags TOM Partner Content News
From Benzinga
Todos Medical Completes Acquisition Of Key Assets And Intellectual Property From NLC Pharma
Tickers TOMDF
Tags Partner Content Benzinga General
From Benzinga
Todos Medical To Present At The Emerging Growth Conference
Tickers TOMDF
Tags General Partner Content Benzinga
From Benzinga
Todos Medical Appoints Greg Meiselbach As Vice President Of Government Affairs
Tickers TOMDF
Tags General Partner Content Benzinga
From Benzinga
Abbott Labs Outlook Cools the Omicron Led Testing Boom
Tickers ABT CODX LH MRK
Tags Market News ABT Biotech
From Benzinga
Todos Medical And NLC Pharma Announce Primary And Secondary Endpoints Met In NLC-V-01 Phase 2 Clinical Trial Of Oral Antiviral 3CL Protease Inhibitor Tollovir™ In The Treatment Of Hospitalized COVID-1
Tickers TOMDF
Tags Benzinga Partner Content General
From Benzinga
Todos Medical Announces Data Lock in Tollovir™ Phase 2 Clinical Trial for the Treatment of Hospitalized COVID-19 Patients
Tickers TOMDF
Tags Market News Penny Stocks Biotech
From Benzinga
PEPPERDINE UNIVERSITY HOSTS THE 22ND ANNUAL CELEBRITY FLAG FOOTBALL CHALLENGE®, PRESENTED BY TODOS MEDICAL'S TOLLOVID®
Tickers TOMDF
Tags Benzinga Partner Content General
From Benzinga
Todos Medical Releases Videos of Recent CEO Interviews with Fox Business, NewsMax and Black News Channel on COVID Testing & Treatment Strategies
Tickers MRK PFE TOMDF
Tags Partner Content Benzinga General
From Benzinga
Todos Medical to Announce Topline Results from Tollovir™ Phase 2 Clinical Trial from the Treatment of Hospitalized COVID-19 Patients on January 27th, 2022
Tickers TOMDF
Tags Biotech Market News Penny Stocks
From Benzinga
Todos Medical CEO to Appear on Fox Business to Talk COVID Testing & Tollovir™ on Tuesday, January 11, 2022 and is Presenting at Biotech Showcase 2022
Tickers TOMDF
Tags Partner Content Benzinga General
From Benzinga
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
Tickers TOMDF
Tags General Partner Content Benzinga
From Benzinga
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
Tickers CYDY GILD GSK LLY
Tags Todos Medical Health Care MRK
From Benzinga
Todos Medical CEO to Appear on Yahoo Finance Live! at 12:10PM EST with Akiko Fujita to Talk Pfizer's Paxlovid Approval, Tollovir™ Phase 2 & COVID Testing
Tickers PFE TOMDF
Tags PFE General Benzinga
From Benzinga
Todos Medical Announces New cPass Neutralizing Antibody Testing Reference Lab Agreement for CLIA/CAP Lab Provista with Physician Group in 40 States
Tickers TOMDF
Tags Todos Medical Press Releases Penny Stocks
From Benzinga